RNF130 and plasma cell myeloma: By MSP, methylation of RNF130/miR-340 was detected in 4 (22.2%) MGUS, 15 (23.8%) diagnostic myeloma, and 7 (23.3%) relapsed myeloma primary bone marrow samples (Fig. 3a).